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Self-reactive T cell clones that escape negative
selection are either deleted or rendered functionally
unresponsive (anergic), thus preventing them from
propagating host tissue damage. By using an
in vivo model, we investigated molecular mecha-
nisms for T cell tolerance, finding that despite a char-
acteristic inability to generate effector cytokine pro-
teins, self-reactive T cells express large amounts of
cytokine mRNAs. This disconnect between cytokine
message and protein was not observed in T cells
mounting productive responses to foreign antigens
but, instead, was seen only in those responding
to self, where the block in protein translation was
shown to involve conserved AU-rich elements within
cytokine 30UTRs. These studies reveal that transla-
tion of abundant cytokine mRNAs is limited in self-
reactive T cells and, thus, identify posttranscriptional
silencing of antigen-driven gene expression as a key
mechanism underlying the anergic phenotype of self-
reactive T cells.
INTRODUCTION
Self-reactive clonesmake up a considerable fraction of the post-
thymic T cell repertoire and are a driving force in many clinically
relevant inflammatory disorders, including arthritis, diabetes,
and multiple sclerosis. However, despite the constant threat of
self-reactivity, autoimmune disease is rare, in large part because
these potentially dangerous clones are kept at bay through
a process known as peripheral T cell tolerance (Mueller, 2010;
Schwartz, 2003). The current paradigm holds that, under homeo-
static conditions, self-reactive T cells encounter cognate antigen
in the absence of overt inflammation, such that they receive a
T cell receptor (TCR) trigger in the context of low-level costimu-
lation and few proinflammatory cytokines. This suboptimal
stimulus is interpreted as a ‘‘tolerogenic’’ signal and, in turn,
self-reactive T cells are either deleted (apoptosis) or rendered
functionally unresponsive (anergy), thereby preventing host50 Immunity 34, 50–60, January 28, 2011 ª2011 Elsevier Inc.tissue damage (Fathman and Lineberry, 2007; Schwartz,
2003). Alternatively, a subset of self-reactive T cells can become
peripheral T regulatory (Treg) cells which, despite having critical
immunosuppressive functions, also display at least one defining
feature of T cell anergy—the inability to produce effector cyto-
kines in response to antigenic stimulation (Bluestone and Abbas,
2003).
Although it has long been known that anergic, self-reactive
T cells can persist for long periods (Pape et al., 1998), the molec-
ular mechanisms underlying T cell anergy remain poorly defined.
One key unresolved issue is whether self-reactive T cells fail to
produce effector cytokines because of a direct block in cytokine
gene expression or because of their general inability to respond
to antigen. Regarding the former, there is evidence that cytokine
transcription is suppressed in anergic T cells, with epigenetic
silencing, induction of regulatory factors, and suppression
of inducing factors all having been proposed as mechanisms
(Fathman and Lineberry, 2007; Schwartz, 2003). However,
though cytokine transcription may be impaired, it is also known
that cytokine mRNAs can be detected within the ‘‘transcrip-
tome’’ of anergic T cells, which suggests that transcriptional inhi-
bition alone may not account for their cytokine null phenotype
(Knoechel et al., 2006; Macian et al., 2002). Regarding the latter,
it is well established that cytokine production is strongly influ-
enced by the TCR and, because TCR-derived signals are known
to be depressed in anergic T cells, some have proposed that the
cytokine phenotype is secondary to their overall unresponsive
state. Consistent with this idea, numerous studies have shown
that, once self-reactive T cells are rendered anergic, they
become refractory to stimulation with cognate antigen, even
when presented in a highly immunogenic context (Schwartz,
2003). Moreover, when the molecules thought to underlie
‘‘TCR desensitization’’ are deleted or blocked, it typically leads
to a break in peripheral T cell tolerance and attendant immuno-
pathology, as in mice lacking cytotoxic T-lymphocyte-associ-
ated protein 4 (CTLA4), programmed cell death 1 (PD1), or
Casitas B-lineage lymphoma b (Cbl-b), among others, and
mice engineered to have constitutive or enhanced TCR signaling
(Fathman and Lineberry, 2007; Mueller, 2010; Sonnenberg et al.,
2010). However, despite a wealth of data indicating that anergic
cells have a block in TCR signaling, it is also recognized that
antigenic stimulation is necessary for the induction of T cell
anergy and that, when removed from persistent antigen, anergic
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which, paradoxically, suggests that TCR-derived signals are
required to maintain the unresponsive state (Rocha et al.,
1993; Schwartz, 2003). Accordingly, when T cells are deprived
of ‘‘tolerogenic’’ TCR signals it also leads to a break in peripheral
T cell tolerance, as in mice with loss-of-function mutations in the
TCR signaling molecule LAT, mice that have been depleted of
tolerogenic dendritic cells and mice with T cell-specific deletion
of calcium sensors (Mingueneau et al., 2009; Oh-Hora et al.,
2008; Ohnmacht et al., 2009).
By using an in vivo model, we addressed the issue of why self-
reactive T cells fail to produce effector cytokines. We demon-
strate that, in response to high-affinity antigen, self-reactive
T cells can express high amounts of cytokine mRNA but do not
generate the corresponding proteins because of a cytokine-
specific block in mRNA translation. Our studies also reveal
that the disconnect between message and protein is mediated
by conserved sequences within the 30UTR of cytokine mRNAs,
particularly AU-rich elements. Based on these data, we propose
that posttranscriptional silencing of effector cytokines underlies
the anergic phenotype of self-reactive T cells and that, in
general, posttranscriptional control of antigen-driven gene
expression is critical for T cell tolerance.
RESULTS
Self-Reactive T Cells Fail to Produce Effector Cytokines
in Response to Antigenic Stimulation
To study cell-intrinsic mechanisms of peripheral tolerance, we
have developed a mouse model where T cells bearing a high-
affinity TCR specific for chicken ovalbumin (DO11) are adoptively
transferred intomice that express ovalbumin as a soluble protein
in the bloodstream, representing a neo-self antigen (sOva) (Lohr
et al., 2004). As our basic experimental set-up, donor CD4+
T cells were purified from DO11 TCR transgenic mice crossed
onto a Rag2-deficient background, thus yielding a starting pop-
ulation that is monoclonal and devoid of memory or regulatory
lymphocytes (Figure S1 available online). These were adoptively
transferred into sOva hosts, where they encountered antigen in
a tolerogenic setting; WT hosts, where they did not encounter
antigen; or WT hosts that were then immunized with Ova-pulsed
dendritic cells (Ova-DC), where they encountered antigen in an
inflammatory setting. At various times posttransfer, lymph nodes
(LNs) and spleens were dissected from recipient mice and donor
T cells were visualized with a monoclonal antibody that specifi-
cally recognizes the DO11 TCR (Figure S1). Consistent with
previous reports (Lohr et al., 2004), we found that DO11 T cells
exhibited a short bust of antigen-driven proliferation followed
by a steep contraction phase when transferred into sOva hosts.
A similar pattern was observed in the Ova-DC-immunized
group, though the initial expansion was greater and subsequent
decline less dramatic (Figure 1A; Figure S1). There was also
a difference in the site of donor T cell proliferation such that, in
sOva hosts, accumulation was greater in the LNs whereas, in
Ova-DC hosts, it was greater in the spleen. Given that naive
T cells homed to LNs in unimmunized WT mice, and that sOva
mice express high amounts of antigen within the LNs, we
conclude that the preferential expansion in sOva hosts is a func-
tion of where antigen was first encountered and not a funda-mental biological feature of the tolerogenic response. According
to that logic, it is also likely that preferential expansion in Ova-DC
hosts is due to migration of the immunizing DCs, which are
known to accumulate in the spleen upon intravenous administra-
tion. Accordingly, we found similar quantitative changes in the
expression of cell-surface activation markers, including CD25,
CD44, CD69, and CD62L, when comparing the LNs of sOva
hosts to the spleens of immunized Ova-DC hosts (Figure 1A; Fig-
ure S1; data not shown).
To measure effector cytokine production, CD4+ cells were
purified from recipient mice, restimulated overnight with Ova-
pulsed dendritic cells, then fixed and stained for intracellular
flow cytometry (IFC). As expected, there were few IL-2+, IL-4+,
IL-13+, or IFN-g+ donor T cells in sOva hosts although these
were all readily detected in immunized Ova-DC hosts (Figures
1B and 1C). We did observe a small number of IL-17+ donor
T cells in sOva hosts, though the percentage and amount of cyto-
kine produced per cell were both lower than in Ova-DC hosts,
leading us to conclude that, like Th1 and Th2 cell, Th17 cell differ-
entiation is restricted in anergic cells. Consistent with this latter
point, we could not detect IL-2, IL-4, IL-17A, or IFN-g in culture
supernatants from sOva hosts but could in those from Ova-DC
hosts (Figure 1D). We also noted that donor T cell cytokine
production was equally depressed in the LNs and spleens of
sOvamice, which confirms that there is no site-specific influence
on T cell anergy in this model (Figure S1 and data not shown).
In somemodels of T cell tolerance, anergic T cells can produce
effector cytokines when exposed to polyclonal mitogens that
bypass the TCR, such as PMA or ConA (Schwartz, 2003). To
ask whether this applies to sOva hosts, we performed adoptive
transfers, then measured donor T cell cytokine production in
response to the combination of PMA and ionomycin. Consistent
with previous reports (Macian et al., 2002; Teague et al., 2008),
we found that donor T cells could produce IL-2 when exposed
to this mitogenic cocktail, which confirms that TCR-dependent
mechanisms can impact cytokine production in the context of
T cell tolerance (Figure S1). However, production of lineage-
restricted cytokines, like IFN-g, IL-4, and IL-17, was not
‘‘released’’ under these conditions, which suggests that TCR-
dependent mechanisms alone may not account for the general
cytokine-null phenotype of anergic T cells (Figure S1). Collec-
tively, the data presented in this section also indicate that,
despite bearing an ‘‘activated’’ surface phenotype, self-reactive
T cells are indeed limited in their capacity to produce effector
cytokines and, thus, are functionally impaired.
Cytokine Transcripts Are Abundant in Self-Reactive
T Cells
To further investigate the cytokine-null phenotype of self-reac-
tive T cells, we performed adoptive transfers, then purified
antigen-experienced (CD4+CD44hi DO11) donor cells and used
real-time PCR to measure cytokine mRNAs (Figure S2). Surpris-
ingly, we found that, despite their inability to generate effector
cytokine proteins, donor T cells from sOva mice had an abun-
dance of cytokine mRNAs. In fact, transcript levels for IL-2,
IL-4, IL-13, IL-17A, IL-17F, IL-21, IFN-g, and TNF-awere compa-
rable to and often greater than those seen in donor T cells from
Ova-DC-immunized hosts, which suggests that antigen-driven
transcription of these genes is a common feature of T cellsImmunity 34, 50–60, January 28, 2011 ª2011 Elsevier Inc. 51
Figure 1. Self-Reactive T Cells Fail to Poduce Effector Cytokines during Ex Vivo Restimulation
(A) DO11 T cells were transferred into WT (naive), sOva (anergic), or WT mice, which were then immunized with Ova-pulsed DCs (effector). At 5–10 days post-
transfer (P.T.), LNs and spleens were dissected from recipient mice and the percentage of total or activated (CD44hi) donor T cells was measured by flow cytom-
etry. Total numbers were calculated by multiplying the percentage of CD4+DO11+ events by the number of viable cells recovered. Data are compiled from five
experiments. Error bars indicate standard deviation between individual experiments, and asterisks denote significant differences between the effector (Ova-DCs)
and anergic (sOva) groups (p < 0.05).
(B) CD4+ cells from recipient mice were restimulated and cytokine production measured by flow cytometry (day 5). Only CD4+DO11+ events are shown and
percentages denote the cytokine-positive fraction within each quadrant.
(C) Flow cytometry data are compiled from four to five experiments. Error bars indicate standard deviation between individual experiments, and asterisks denote
significant differences between the effector and anergic groups (p < 0.05).
(D) CD4+DO11+ donor T cells were purified from recipient mice (day 5) and restimulated, and cytokine production measured by ELISA. Data are representative of
three experiments and error bars indicate the standard deviation between experimental replicates.
See Figure S1 for supplemental data on donor T cell behavior in sOva hosts.
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tent with published reports (Grogan et al., 2001), we also found
that naive T cells (from donor DO11 mice) had detectable levels
of some cytokine transcripts but, in most cases, these were
orders of magnitude lower than in the other experimental groups
which, again, suggests that TCR-derived signals are key for
driving cytokine transcription (data not shown). In addition,
though recent studies have shown that some ‘‘inducible’’ genes
constitutively produce low levels of unspliced transcripts (Har-
greaves et al., 2009), the majority of IFN-g and IL-4 mRNAs
were fully spliced in donor T cells from sOva and Ova-DC hosts,
making it unlikely that differences in mRNA processing account
for their distinct protein outputs (Figure S3).
Similar to effector cytokines like IL-4 and IFN-g, we also found
that mRNA expression for IL-10, a regulatory cytokine, was52 Immunity 34, 50–60, January 28, 2011 ª2011 Elsevier Inc.higher in donor T cells from sOva hosts than in those from
Ova-DC hosts (Figure 2B). However, as above, we could detect
IL-10 protein only in the immunized Ova-DC group, which
suggests that the translational block associated with T cell
anergy is not limited to overtly proinflammatory factors (data
not shown). mRNA for TGF-b, another regulatory cytokine, was
also slightly enriched but, in this case, expression was also
high in naive controls and the difference between sOva hosts
and the other groups was less than 2-fold. EBI3, a component
of the regulatory cytokine IL-35, was strongly induced in both
sOva and Ova-DC hosts but its partner in this heterodimer,
IL-12p35, was not detected in any of the experimental groups
(Figure 2B).
To visualize cytokine transcription directly ex vivo and at
the single-cell level, we crossed DO11 donors with ‘‘cytokine
Figure 2. Cytokine mRNAs Are Abundant in
Self-Reactive T Cells
(A) Adoptive transfers were performed as in Fig-
ure 1. At 5–10 days posttransfer, CD4+DO11.10+
CD44hi donor cells were purified from pooled
LNs and spleens of recipient mice and cytokine
mRNAs measured by PCR (Figure S2). Data are
representative of five experiments and are pre-
sented as the fold increase (X > 1) or decrease
(X < 1) relative to naive controls (Nv = 1). Error
bars indicate the standard deviation between
experimental replicates.
(B) Cytokine mRNAs were measured on day 5
posttransfer. LPS-activated DCs are included as
a positive control (Ctl). Data are representative of
three experiments and error bars indicate the stan-
dard deviation between experimental replicates.
See Figures S2 and S3 for supplemental data on
donors T cell purification, PCR controls, and
measurement of cytokine mRNA splicing.
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stream of the endogenous IFN-g and IL-4 loci, respectively
(Mohrs et al., 2001; Stetson et al., 2003). The resulting double-
transgenic offspring were not on a Rag2-deficient background
so, to ensure that only naive, antigen-specific cells were used,
CD4+CD25YFP or GFP DO11 cells were sorted prior to
transfer (Figure S4). As with our PCR studies, we saw little
expression of YFP or GFP in WT Balb/c hosts but found clear
induction in sOva and Ova-DC hosts. For both, fluorescence
was linked to increased expression of CD44, meaning that it
was dependent on antigenic stimulation and was heteroge-
neous, with some cells ‘‘brighter’’ than others (Figures 3A and
3B). To ask whether transgene expression was associated withFigure 3. Translation of Effector Cytokines Is Limited in Self-Reactive
(A andB) Naive donor T cells were purified from (A) Yeti-DO11 or (B) 4get-DO11 cy
5 days later, YFP and GFP fluorescence was measured by flow cytometry. Only C
iments and asterisks denote significant differences between the indicated group
(C and D) YFP+ or GFP+ donor cells were purified from recipient mice, and produc
from two to three experiments. Error bars indicate standard deviation between in
indicated group and naive controls (p < 0.05). See Figure S4 for supplemental daprotein expression, we restimulated YFP- and GFP-positive
donor cells from sOva and Ova-DC hosts, then quantified IFN-g
and IL-4 production by ELISPOT, which is considered among the
most sensitive metrics. Consistent with our flow cytometry
studies (Figure 1), we found that YFP- and GFP-positive donor
cells from sOva hosts could not produce IFN-g or IL-4 whereas
those from Ova-DC hosts could (Figures 3C and 3D). These
data indicate that, even when actively transcribing effector cyto-
kine loci, anergic T cells cannot generate the corresponding
cytokine proteins.
To confirm that increased expression of cytokine mRNAs is
a general feature of self-reactive T cells, and not unique to our
adoptive transfer system, we crossed 4get-DO11 mice withT Cells
tokine reporter mice (Figure S4). Thesewere transferred into recipientmice and,
D4+DO11+ events are shown. Right: Data are compiled from four to five exper-
and naive controls (p > 0.05).
tion of IFN-g or IL-4 wasmeasured by ELISPOT (day 5). Left: Data are compiled
dividual experiments, and asterisks denote significant differences between the
ta on donor T cell purification from cytokine reporter mice.
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Figure 4. Expression of Cytokine mRNAs in Self-Reactive T Cells
that Escape Negative Selection
(A) LNs were dissected from 4get, 4get-sOva, 4get-DO11, and 4get-DO11-
sOva mice. Shown is the percentage of CD4+DO11+ cells within the total
lymphocyte population. Data are representative of four experiments.
(B) Lymphocytes from double- and triple-transgenic mice were restimulated
and IL-2 production measured by flow cytometry. Only CD4+ events are
shown. Right: Data are compiled from three experiments.
(C) Flow cytometry was performed as in (A). Only CD4+DO11+ events are
shown and percentages represent the fraction of GFP+ cells. Right: Data are
compiled from four experiments.
(B and C) Asterisks denote significant differences between the indicated group
and either DO11 or 4get-DO11 controls (p < 0.05).
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bination of single-, double-, and triple-transgenic offspring.
Predictably, we found very few CD4+DO11+ cells in either 4get
or 4get-sOva mice whereas these were abundant in 4get-
DO11 mice, comprising nearly 30% of all lymphocytes and
10% of all splenocytes (Figure 4A and data not shown). Because
of negative selection, the percentage of CD4+ DO11 cells
was dramatically reduced in 4get-DO11-sOva triple-transgenic
mice but, as with the adoptive transfer system, there also re-
mained an anergic population, here characterized by reduced
TCR levels and an inability to produce IL-2 (Figures 4A and 4B
and data not shown). A substantial percentage of these CD4+
DO11 cells also expressed GFP in triple-transgenic mice, which
confirms that some are undergoing posttranscriptional silenc-
ing of abundant IL-4 transcripts (Figure 4C). Together with our
adoptive transfer studies, these data indicate that, beyond dele-
tion of self-reactive clones, peripheral T cell tolerance is enforced
by posttranscriptional mechanisms that limit translation of
abundant cytokine transcripts.Mechanisms for Posttranscriptional Control of T Cell
Cytokine Production
Previous work has shown that the integrated stress response
(ISR), which typically curtails protein synthesis under conditions54 Immunity 34, 50–60, January 28, 2011 ª2011 Elsevier Inc.of stress, can also limit cytokine production during helper T cell
differentiation (Scheu et al., 2006). To ask whether the ISR has
a similar effect in the context of T cell tolerance, we purified
donor cells from sOva and Ova-DC hosts and measured expres-
sion of ATF4, BiP, and CHOP, three critical components of the
ISR. We found that, although these genes were active in all
experimental groups (including naive controls), there was no
specific enrichment in the sOva group, leading us to conclude
that preferential induction of the ISR is unlikely to account for
the observed differences in cytokine output (Figure S5).
Numerous studies have shown that cytokinemRNA translation
can be influenced by sequences within the 30UTR and, specifi-
cally, that AU-rich elements (AREs) can impact both half-life
and translational efficiency (Anderson, 2010; Kruys et al.,
1989). To ask whether UTR-mediated silencing can influence
T cell cytokine production, we engineered a series of ‘‘UTR
sensors’’ where cytokine (or control) UTRs were fused to
GFP, thus allowing for protein levels to be measured by GFP
fluorescence. These were delivered into primary mouse T cells
by means of an MSCV-based vector that, upon integration,
uses its own viral promoter to drive transcription, thereby
assuring that each construct had similar output and that none
would be subject to transcriptional silencing (as is the case for
the endogenous cytokine loci). It should also be noted that naive
T cells could not be transduced with these vectors so, for the
subsequent studies, all T cells were activated with TCR and
CD28 antibodies prior to retroviral (RV) infection. To confirm
that this in vitro manipulation would not affect T cell behavior
in vivo, DO11 T cells were transduced with a control GFP
construct, transferred into sOva hosts and, 5 days later, their
ability to produce effector cytokines was measured. As with
our naive cell transfers (Figure 1), we found that RV-infected
donors could not produce IL-2, IL-4, or IFN-g when restimulated
ex vivo, which demonstrates that neither ‘‘preactivation’’ nor RV
infection had much impact on the anergic phenotype in this
model (Figure S7 and data not shown).
As our first test case, we chose IFN-g, which has a relatively
long 30UTR (631 bp) and a clear stretch of AU-rich sequence
proximal to the stop codon. We generated a full-length construct
(FL), which has the entire 30UTR sequence downstream of
GFP, and two truncated mutants, one containing the AREs
(M1, bases 1–279) and one lacking them (M2, bases 279–631).
As an additional control, we also generated a construct with
the 30UTR of GAPDH, which is relatively short (200 bp) and not
known to undergo posttranscriptional silencing (Figure S6). We
found that T cells could be readily transduced by all of these
constructs, with each yielding a comparable percentage of
GFP+ cells, but we also noted that the full-length and M1
constructs had lower mean fluorescence intensity (MFI) (Figures
5A and 5B). To further investigate this effect, we purified GFP+
cells from all groups and used PCR to quantify GFP transcripts.
As with our protein measurements, we found that less GFP
mRNA could be detected in cells transduced with the FL and
M1 constructs than in those transduced with the GAPDH or
M2 constructs, which suggests that, beyond translational
effects, the IFN-g UTR may also prompt mRNA decay (Fig-
ure 5B). Consistent with these findings, and the idea that multiple
cytokines are influenced by UTR-dependent mechanisms, GFP
protein and message were also depressed in cells transduced
Figure 5. 30UTR-Dependent Mechanisms Limit Translation of Ifng and Il4 mRNAs
(A) CD4+ T cells were transduced with UTR-sensor constructs and GFP fluorescence measured by flow cytometry. Shown is the percentage of GFP+ cells (top
left) and the mean fluorescence intensity of those GFP+ events (vertical).
(B) Flow cytometry and PCR data are compiled from three to four in vitro experiments. For PCR experiments, GFP+ cells were purified by high-speed cell sorting
and assayed as in Figure 2. Fold change was calculated by dividing experimental group measurements by those of GAPDH controls (G = 1).
(C) CD4+ T cells were transduced with the GAPDH, IFN-g (FL), or IFN-gM3 (AREmutant) 30UTR constructs and GFP fluorescence measured as in (A). Right: Data
are compiled from two experiments.
(B and C) Error bars indicate standard deviation between individual experiments, and asterisks denote significant differences between the indicated group and
GAPDH controls (p < 0.05).
See Figures S5 and S6 for supplemental PCR data, information about UTR-sensor construct design, and bioinformatic analysis of cytokine 30UTRs.
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contains a prominent AU-rich region (Figures 5A and 5B;
Figure S6).
To directly address the role of AREs in limiting T cell cyto-
kine production, we started with a computational approach.
Sequence analysis revealed that, indeed, the cytokine mRNAs
that we found to be enriched in anergic T cells, like IL-4, IL-21,
and IFN-g, all had predicted AREs within their 30UTRs (Table 1).
In most cases, the AREs were located within highly conserved
regions of the 30UTR, with IL-17A and IL-17F being the excep-
tions and IFN-g themost representative, exhibiting a high degree
of conservation in the proximal AU-rich region (corresponding to
the M1 construct) and much less in the distal ‘‘AU-poor’’ region
(Figure S6). To test the biological impact of these conserved
AREs, we mutated our full-length IFN-g 30UTR construct such
that predicted AREs were substituted with GC-rich sequence
(Figure S6). As before, the construct was packaged into retro-
virus (along with controls) and transduced into primary mouseT cells and, 24 hr later, GFP fluorescence was measured. We
found that, compared to the WT construct (IFN-g 30UTR-FL),
GFP fluorescence was substantially higher in the ARE mutant
(Figure 5C). Taken together with our truncation mutant studies
(Figure 5A), these data support the hypothesis that 30UTR-
dependent mechanisms curb T cell cytokine production and
identify AREs as key mediators in that process.
To test whether UTR- and ARE-mediated silencing are rele-
vant in the setting of T cell tolerance, we transduced DO11
cells with UTR-sensor constructs, then purified the GFP-positive
fraction and transferred them into sOva hosts. We found that,
compared to GAPDH, the FL and M1 constructs had greatly
reduced fluorescence both in terms of MFI and in terms of
percent GFP+ cells, which suggests that many were suppressed
to below the limit of detection (Figures 6A and 6B). By compar-
ison, the M2 construct was only slightly lower than the GAPDH
control, though it should be noted that the M1 construct was
not as dim as the FL construct, which implies that beyond theImmunity 34, 50–60, January 28, 2011 ª2011 Elsevier Inc. 55
Table 1. Sequence and Position of AU-Rich Elements within Cytokine 30UTRs
Gene Accession UTR Length AU-Rich Element Sequence Position ARED Cluster
Ifng NM008337 631 yes TGTTATTTATAAT 188–200 5
Tnf NM013693 754 yes ATTTATTTATTTG 458–470 3
Il2 NM008366 382 yes CTATTTATTTAAA 35–47 4
Il4 NM021283 96 yes ATTTATATATTTA 53–65 3
Il10 NM010548 702 yes AAATATTTATTAC 125–37 5
Il13 NM008355 741 yes TCTTATTTATTAT 304–16 5
Il17a NM010552 637 yes ATTTGTTTATTTA 472–84 3
Il17f NM145856 618 yes ATATATTTATGTT 504–16 5
Il21 NM021782 2578 yes GATTATTTATTAT 2491–503 5
Tgfb1 NM011577 54 no
Ebi3 NM015766 245 no
Ifnb1 NM010510 201 no
Gapdh NM008084 180 No
ARED Cluster refers to the type of AU-rich element, as defined by the AU-Rich Element mRNA Database (ARED, http://brp.kfshrc.edu.sa/ARED).
Immunity
Translational Control of T Cell Cytokine ProductionAU-rich M1 region, there may be a contribution from the more
distal M2 region. As with our in vitro experiments (Figure 5C),
we found that GFP fluorescence was greater in the ARE mutant
than in the wild-type IFN-g construct, which provides direct
evidence for the involvement of AREs in the context of T cell
anergy (Figure 6C). Also, like our in vitro experiments, GFP
fluorescence was strongly depressed in cells transduced with
the IL-4 30UTR construct which, again, demonstrates that
multiple cytokines may be subject to 30UTR-dependent regula-
tion (Figures 6A and 6B).
Previous work has shown that, when DO11 T cells are trans-
ferred into lymphopenic sOva mice (crossed onto a Rag2-defi-
cient background), they do not become anergic and, instead,
generate a robust effector response characterized by unre-
strained IFN-g production (Caretto et al., 2010). To test whether
UTR-mediated inhibition can be relieved under these permissive
conditions, we transduced DO11 T cells with UTR-sensor con-
structs and transferred them into sOva Rag2/ mice. Unlike
‘‘intact’’ sOva hosts, where there was robust inhibition of the
full-length and M1 constructs, we found that the percent of
GFP+ cells was similar for all groups in lymphopenic hosts (Fig-
ure 6D). Taken together with our studies in ‘‘lymphoreplete’’
hosts (sOva Rag2+/+), these data argue that 30UTR- and ARE-
dependent mechanisms can prohibit cytokine translation in
a ‘‘tolerogenic’’ setting but not in a lymphopenic or ‘‘autoim-
mune’’ setting, which suggests that posttranscriptional silencing
is either shut down or overcome when T cells are primed under
proinflammatory conditions.
DISCUSSION
The studies presented here establish that, in response to
high-affinity antigen, self-reactive T cells can express cytokine
mRNAs but fail to generate the corresponding proteins because
of a block in translation that involves AU-rich elements within
cytokine 30UTRs. A similar disconnect between protein and
message has been observed in other cell types, including NK
cells, NKT cells, neutrophils, and basophils but, in these line-
ages, it has generally been viewed as a proinflammatory event,56 Immunity 34, 50–60, January 28, 2011 ª2011 Elsevier Inc.an indication that they are poised for rapid cytokine production
(Gessner et al., 2005; Stetson et al., 2003). It is also known
that, when helper T cells become activated, cytokine transcrip-
tion is rapidly induced while translation lags behind, thereby
creating a circumstance where cytokine message is abundant
but protein is scarce. In those studies, it was revealed that anti-
genic stimulation triggers the integrated stress response (ISR)
and that this is responsible for the lag in cytokine production
during the early stages of differentiation (Scheu et al., 2006).
Though we did not find that the ISR was selectively active in
anergic T cells (compared to naive or effectors), the 30UTR-
dependent mechanisms described here are likely to work in
concert with the ISR, which is 50 cap dependent, and with other
50UTR-mediated processes (Anderson, 2010; Ben-Asouli et al.,
2002; Mazumder et al., 2010). Therefore, based on current and
past findings, we propose that multiple 50 and 30UTR-dependent
pathways cooperate to limit translation of effector cytokine
mRNAs in anergic, self-reactive T cells. We also put forth that,
although numerous cytokines may be affected, this translational
block is cytokine specific and does not represent a global shut-
down in protein synthesis, as evidenced by our own studies,
which demonstrate that cell-surface markers like CD25, CD44,
and CD69 are strongly induced in anergic T cells, and by
numerous others which have shown that certain molecules are
selectively expressed under tolerogenic conditions (Fathman
and Lineberry, 2007; Schwartz, 2003).
It is well established that the 30UTR can act as a platform for
posttranscriptional regulation of cytokine mRNAs (Anderson,
2010). Accordingly, we hypothesize that AREs within the 30UTR
of cytokine mRNAs limit translation in self-reactive T cells, a con-
clusion supported by numerous in vitro studies demonstrating
that AREs promote decay and/or translational arrest of cytokine
transcripts, and by the phenotypes of mice lacking AREs in the
UTRs of TNF-a and GM-CSF, which exhibit aberrant cytokine
production and severe autoimmune disease (Carballo et al.,
1998; Garcia-Sanz and Lenig, 1996; Han et al., 1990; Houzet
et al., 2001; Kontoyiannis et al., 1999; Kruys et al., 1989; Taylor
et al., 1996). However, it should be noted that ARE-independent
mechanisms are also likely to influence cytokine production in
Figure 6. AU-Rich Elements Limit Translation of Cytokine mRNAs in Self-Reactive Cells
(A) DO11 T cells were transduced as in Figure 5. CD4+DO11+GFP+ cells were then purified by high-speed cell sorting (top) and transferred into sOva hosts
(bottom). 3–5 days later, CD4+ cells were purified from pooled LNs and spleens of recipient mice and GFP fluorescence was measured by flow cytometry.
Only CD4+DO11+ events are displayed. Shown is the percentage of GFP+ cells (top left) and the mean fluorescence intensity of those GFP+ events (vertical).
(B) Flow cytometry data are compiled from three to four experiments. Fold change was calculated by dividing experimental group measurements by those of
GAPDH controls (G = 1).
(C) DO11 T cells were transduced with the GAPDH, IFN-g (FL), or IFN-g M3 (ARE mutant) 30UTR constructs. Adoptive transfers and flow cytometry were then
performed as in (A). Right: Data are compiled from two experiments.
(D) Donor T cells were transduced and sorted as in (A). These were then transferred into sOva Rag2/ recipients and, 5 days later, GFP fluorescence was
measured. Right: Flow cytometry data are compiled from three experiments.
(B–D) Error bars indicate standard deviation between individual experiments, and asterisks denote significant differences between the indicated group and
GAPDH controls (p < 0.05).
See Figure S7 for supplemental data on effector cytokine production in RV-transduced donor T cells.
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Translational Control of T Cell Cytokine Productionthis setting. For instance, there is a growing list of RNA-binding
proteins (RBPs), including Roquin, 4E-BP1, Zc3h12a, and
Zcchc11, that are known to affect cytokine production, and
many of these could be relevant in helper T cells (Colina et al.,
2008; Jones et al., 2009; Matsushita et al., 2009; Yu et al.,2007). Another class of regulatory factor that could impact cyto-
kine production are microRNAs, short (20–25 nt) single-stranded
RNAs, which target complementary sequences within 30UTRs,
thereby silencing the associated transcripts. Consistent with
this latter point, T cells lacking Dicer, an enzyme necessary forImmunity 34, 50–60, January 28, 2011 ª2011 Elsevier Inc. 57
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tion, and an increasing number of individual microRNAs have
been shown to directly interact with cytokine mRNAs (Jones
et al., 2009; Matsushita et al., 2009; Muljo et al., 2005; Sharma
et al., 2009; Zhou et al., 2008).
Based on our data, which demonstrate that posttranscrip-
tional mechanisms limit cytokine production in the context of
T cell tolerance, and studies showing that naive T cells can
express cytokine mRNAs (Grogan et al., 2001), we propose
that there is a translational threshold that prevents T cells from
generating effector cytokines until they encounter requisite
inflammatory cues, such as would be provided during acute
infection or immunization. Consistent with this hypothesis, we
demonstrate that cytokine translation is repressed under tolero-
genic conditions (sOva mice) and derepressed under autoim-
mune conditions (sOva Rag2/ mice), which confirms that the
translational threshold can be overcome when T cells are primed
in a permissive environment. The mechanism(s) for that effect
remains unknown but several theories can be proposed. One
possibility is that, when T cells are exposed to polarizing stimuli,
they generate enough cytokinemRNAs to overwhelm the regula-
tory machinery, thus allowing some translation to proceed. It is
also possible that the regulatory machinery is shut down when
T cells become activated, which would lead to increased trans-
lation without a vast excess of cytokine message, or that protein
synthesis is turned up, which would lead to increased translation
of all mRNAs, not just those encoding cytokines. These three
ideas are notmutually exclusive and do not represent an exhaus-
tive list, but there is already some evidence for the second, with
recent studies demonstrating that mRNAs from activated T cells
tend to have shorter UTRs than those from naive cells, making
them less susceptible to the type of ARE-mediated regulation
described here (Sandberg et al., 2008).
By using an in vivo model, we demonstrate that self-reactive
T cells express cytokine mRNAs and that, on a per cell basis,
the amount is similar to that observed in ‘‘cytokine-competent’’
effector T cells. Although this seems to be at odds with the
idea that cytokine transcription is depressed under tolerogenic
conditions (Macian et al., 2002), it should be noted that previous
work employed mostly in vitro models, which are known to
induce a different type of anergy, often termed ‘‘clonal anergy’’
(Schwartz, 2003), and that despite this difference in method-
ology, they also offer some evidence that anergic T cells can
express cytokine mRNAs (albeit at lower amounts than effector
counterparts). Thus, we propose that pre- and posttranscrip-
tional mechanisms cooperate to limit cytokine production in
the context of T cell tolerance. In addition, given the widespread
use of gene arrays (and PCR) to measure T cell responses, we
also suggest that cytokine transcripts do not always equate to
protein and that, as a result, mRNA data must be interpreted
with care and, whenever possible, confirmed by means of
protein-based measurements.
Numerous posttranscriptional mechanisms are known to
impact T cell tolerance, including RBPs, phosphatases, kinases,
and ubiquitin ligases, and it is certain that others will emerge,
particularly in the field of microRNAs where the discovery of
immunologically relevant targets has only just begun (Fathman
and Lineberry, 2007; Mueller, 2010; Schwartz, 2003). Our work
builds on this idea and, though we have considered only a select58 Immunity 34, 50–60, January 28, 2011 ª2011 Elsevier Inc.group of factors (cytokines) within only one cell type (CD4+
helper T cells), we hypothesize that 30UTR-mediated silencing
may be a general paradigm for limiting the expression of inflam-
matory gene products, affecting multiple classes of proteins
(i.e., costimulatory molecules, cytolytic molecules) and multiple
immune cell lineages (i.e., NK cells, dendritic cells), an idea
bolstered by recent work demonstrating that granzyme-B (in
CD8+ T cells) and IL-10 (in NKT cells) are also subject to posttran-
scriptional control (Fehniger et al., 2007; Maroof et al., 2008).
Thus, based on current and past evidence, we propose that
the components of this regulatory machinery, such as those
involved in UTR- and ARE-dependent inhibition, are relevant
therapeutic targets in the setting of autoimmune disease.
EXPERIMENTAL PROCEDURES
Animals
For donors, DO11.10 TCR transgenics (from K. Murphy, Washington Univer-
sity, St. Louis, MO) were crossed with Rag2/ mice (Jackson Laboratories,
Bar Harbor, ME) or Yeti/4get cytokine reporter mice (from R. Locksley,
UCSF, San Francisco, CA) (Mohrs et al., 2001; Stetson et al., 2003). For recip-
ients, WT Balb/c mice were purchased from Jackson Labs. sOva-transgenic
mice were generated as described and, where indicated, bred onto a Rag2-
deficient background (Lohr et al., 2004). For some studies, sOva and 4get
DO11.10 mice were crossed, thereby generating every combination of
single-, double-, and triple-transgenic offspring. Genotyping was done by
PCR. All animals were maintained in specific-pathogen-free housing at the
University of California, San Francisco, CA, and experiments were carried
out according to guidelines set by the Institutional Animal Care and Use
Committee.
Adoptive Transfers and Immunizations
LNs and spleens were pooled from 4- to 6-week-old DO11 Rag2/mice and
CD4+ cells purified (>96% purity) by positive selection with magnetic beads
(Dynal Beads: Invitrogen, Carlsbad, CA) (Figure S1). For cytokine reporters,
LNs were dissected from Yeti DO11.10 or 4get DO11.10 mice and stained
directly ex vivo with fluorochrome-conjugated CD4, DO11.10 (KJ1-26), and
CD25 antibodies (eBioscience, San Diego, CA). Naive CD4+ DO11.10 TCR+,
CD25, YFP/GFP cells were then purified by high-speed cell sorting (>99%
purity) (Figure S4). For all adoptive transfers, 2–53 105 donor cells were intra-
venously injected into age- and sex-matched recipients (in 400 ml PBS). For
immunizations, donor T cells were transferred into WT Balb/c mice and,
24 hr later, these were intravenously injected with 1–5 3 105 bone marrow-
derived dendritic cells (BM-DCs) that had been activated with LPS and loaded
with Ova peptide (1 mg/ml each; Sigma; St. Louis, MO) (Figure S1).
Ex Vivo Cytokine Production
CD4+ cells were purified from LNs and spleens of recipient mice and
stimulated overnight with LPS/Ova-pulsed BM-DCs (5:1 T cell to DC ratio).
Cultures were then treated with Brefeldin A (10 mg/ml) for 2–3 hr, fixed (4%
paraformaldehyde), permeabilized (0.25% Saponin), and stained with fluoro-
chrome-labeled CD4 and KJ1-26 antibodies in combination with anti-IFN-g,
anti-IL-17A, anti-IL-17F, anti-TNF-a, anti-IL-2, anti-IL-4, and/or anti-IL-13
(eBioscience). Where indicated, purified CD4+ cells were also restimulated
with a combination of Phorbol 12-myristate 13-acetate (PMA 50 ng/ml)
and ionomycin (500 ng/ml; 4 hr total with BFA for the final 2 hr), then
stained as above (Figure S1). All 4-color flow cytometry was performed on
a FACScalibur instrument and analyzed with CellQuest Pro Software (Becton
Dickinson; Franklin Lakes, NJ). For ELISA and ELISPOT, CD4+DO11.10 TCR+,
YFP/GFP+ donor T cells were purified from recipient mice by high-speed cell
sorting (1–5 3 104 cells/well for ELISA and 2–10 3 103 for ELISPOT). These
were restimulated overnight (1:2 T cell to DC ratio) and then assayed for
cytokine production with standard protocols. For all studies, cells were main-
tained in supplemented tissue culture medium (RPMI-1640 with 10% fetal calf
serum, 1% sodium pyruvate, 1% nonessential amino acids, 0.1% b-Mercap-
toethanol, 100 U/ml penicillin, 100 mg/ml /streptomycin; GIBCO/Invitrogen)
Immunity
Translational Control of T Cell Cytokine Productionat a density of 2–4 3 106 cells/ml in round-bottomed 96-well plates (200 ml/
well; Sigma/Costar).
Ex Vivo PCR
CD4+CD44hi DO11 cells from recipient mice, along with naive controls (CD4+
CD25CD44lo DO11 cells from DO11.10 mice), were purified by high-speed
cell sorting (2–10 3 104 per group) (Figure S2). Total RNA was then extracted
and converted to cDNA by means of oligo-dT priming and SuperScript III
reverse transcriptase (100–250 ng RNA per reaction; Invitrogen, Carlsbad,
CA). PCR amplification was performed with SYBR green master mix
(5–10 ng cDNA per reaction; Applied Biosystems, Foster City, CA) via an iQ5
Real-Time PCR thermal cycler (BioRad, Hercules, CA). Primer sequences
and relevant information are provided in Table S1. Reactions were performed
in duplicate, Ct values were normalized to b-actin levels, and fold induction
(n > 1) or reduction (n < 1) calculated (DDCt) with respect to the indicated
controls (n = 1) (Figure S2).
Retroviral Gene Transduction
Mouse IFN-g (FL), IL-4, and GAPDH 30UTRs were PCR amplified with high-
fidelity polymerase and a cDNA library derived from activated, Balb/c CD4+
T cells (Easy A Polymerase; Stratagene, Cedar Creek, TX) (Figure S6). PCR
products were then digested and ligated into a modified MIG-R1 vector
(directly downstream of a destabilized GFP; d4GFP from Clonetech, Mountain
View, CA; restriction enzymes and T4 ligase from NEB, Ipswich, MA). Only re-
combinant clones with 100% sequence homology to the NCBI GenBank
mRNA entry were selected for further amplification (PCR sequencing by
Sequentech, Mountain View, CA; Mini- and Maxi-prep kits from QIAGEN, Ger-
mantown, MD). IFN-gM1 andM2 constructs were PCR amplified (with the full-
length construct as template), then cloned into the MIG-R1-d4GFP vector,
sequenced, and amplified. IFN-gM3was generated by site-directedmutagen-
esis within the full-length IFN-g MigR1 vector (mutagenesis by GenScript,
Piscataway, NJ) (Figure S6). All 30UTR vectors (or ‘‘empty’’ controls) were
transfected into Phoenix packaging cells (together with pCL-Eco helper
plasmid) and the resulting culture supernatants used to infect DO11 CD4+
T cells (Rag2+/+). These were cultured with plate-bound anti-CD33 (1 mg/ml,
Clone: 17A2) and soluble anti-CD28 (0.5 mg/ml, Clone: 37.51) for 48 hr,
exposed to viral supernatant for 1 hr (at 2200 rpm, 19C) and cultured for an
additional 24 hr before flow cytometry or high-speed cell sorting. For adoptive
transfers, purified CD4+GFP+ DO11 cells were intravenously injected into
recipient mice (2–10 3 104 per group) (Figure 6A). 3–5 days later, LNs and
spleens were pooled and CD4+ cells were purified and 1 3 107 stained for
flow cytometry. All contour plots are gated on CD4+ DO11 donor cells and
contain >100 events.
Statistics
Paired Student’s t test (two-tailed) was used to quantify statistical deviation
between experimental groups. In all figures, an asterisk represents significant
differences (p < 0.05).SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at doi:10.1016/
j.immuni.2010.12.014.
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